person

Carolina C.

Country
Italy
Department
2601: U.O.C. Ematologia

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
25
Sites with multiple studies

Has run more than one trial at 25 of 140 partner sites.

Specializations

Hematology and blood disorders

Carolina Copia is involved in clinical research across a broad range of hematologic malignancies and non-malignant hematologic disorders, with particular interest in conditions that affect marrow function, blood cell production, and transfusion dependence.

  • Acute leukemia and chronic myeloid neoplasms
  • Myelodysplastic syndromes and myelofibrosis
  • Multiple myeloma and lymphoma
  • Thalassemia, hemophilia, and immune thrombocytopenia

Her therapeutic focus also includes anemia linked to marrow failure and hemoglobinopathies, reflecting involvement in treatment areas relevant to supportive care and disease control in hematology.

Autoimmune, inflammatory, and allergic disease

Her research landscape includes immune-mediated disorders spanning systemic autoimmunity, chronic inflammatory disease, and allergic conditions, with attention to therapies that modify immune activity across multiple organs.

  • Lupus and lupus nephritis
  • Rheumatologic disease including juvenile idiopathic arthritis
  • Inflammatory bowel disease and eosinophilic gastrointestinal disease
  • Atopic dermatitis, psoriasis, and hidradenitis suppurativa

She is also engaged in trials for myasthenia gravis, urticaria, and other immune dysregulation syndromes, indicating a strong therapeutic interest in conditions driven by aberrant inflammation and autoantibody-mediated disease.

Cardiovascular, thrombotic, and renal disease

Her clinical trial activity extends to major cardiometabolic and vascular diseases, including prevention of thromboembolic events, management of heart failure phenotypes, and kidney disorders with inflammatory or progressive features.

  • Atrial fibrillation and stroke prevention
  • Heart failure, cardiomyopathy, and myocardial infarction
  • Chronic kidney disease, IgA nephropathy, and membranous nephropathy
  • Hypertension, atherosclerotic cardiovascular disease, and thrombosis

She also participates in research on pulmonary arterial hypertension and cardiorenal complications, aligning her work with therapeutic areas that address vascular remodeling, organ protection, and event reduction.

Oncology and solid tumor therapy

Carolina Copia is active in clinical studies across multiple solid tumors and advanced cancers, with emphasis on treatment strategies for disease control in both early and metastatic settings.

  • Breast cancer, including HER2-positive and triple-negative disease
  • Non-small cell lung cancer and small cell lung cancer
  • Renal cell carcinoma, urothelial carcinoma, and hepatocellular carcinoma
  • Colorectal cancer, ovarian cancer, and melanoma

Her oncology profile also includes lymphoma and myeloma-related treatment areas, supporting a broad interest in targeted and immunotherapy-based cancer innovation.

Respiratory, neurologic, and endocrine-metabolic conditions

Her research involvement further covers chronic diseases affecting the lungs, nervous system, and endocrine-metabolic regulation, reflecting a wide therapeutic reach beyond hematology and oncology.

  • Asthma, COPD, and pulmonary fibrosis
  • Multiple sclerosis, epilepsy, and migraine
  • Type 1 diabetes, type 2 diabetes, and obesity
  • Thyroid eye disease, adrenal disorders, and lipid metabolism disorders

She is also linked to studies in neurodevelopmental and psychiatric disorders, including Tourette’s disorder and treatment-resistant behavioral conditions, broadening her therapeutic profile across chronic multisystem disease.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.